Paperpal Prime Logo

Acta Reumatologica Portuguesa : Impact Factor & More

eISSN: 0303-464XpISSN: 0303-464X

Key Metrics

CiteScore
1
Impact Factor
< 5
SJR
Q4Rheumatology
Recommended pre-submission checks
Powered by Paperpal by Editage

Acta Reumatologica Portuguesa Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • Web of Science Web of Science
Overview
Publisher Sociedade Portuguesa de Reumatologia
Language Portuguese,English
Frequency Quarterly
General Details
LanguagePortuguese,English
FrequencyQuarterly
Publication Start Year1973
View less

Looking for the right journals to submit your mansucript?

Upload your manuscript and get a submission readiness score and other journal recommendations.

Check my Paper

Recently Published Papers in Acta Reumatologica Portuguesa

Correspondence on: Real-world safety data of first-line drugs for rheumatoid arthritis: insights from the Portuguese Reuma.pt database.
  • 12 Jun 2026
  • ARP rheumatology
Correspondence on: Serum caspase-1 is correlated with vasculitis activity at diagnosis and associated with all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
  • 6 Feb 2026
  • ARP rheumatology
Large vessel vasculitis: syphilitic aortitis as a reversible mimicker.
  • 1 Feb 2026
  • ARP rheumatology
Emapalumab's role in a severe and treatment-resistant paediatric macrophage activation syndrome.
  • 1 Feb 2026
  • ARP rheumatology
Relapsing polychondritis in a patient treated with Dupilumab.
  • 1 Feb 2026
  • ARP rheumatology
Correspondence on: Real-world safety data of first-line drugs for rheumatoid arthritis: insights from the Portuguese Reuma.pt database.
  • 12 Jun 2026
  • ARP rheumatology
Correspondence on: Serum caspase-1 is correlated with vasculitis activity at diagnosis and associated with all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
  • 6 Feb 2026
  • ARP rheumatology
Large vessel vasculitis: syphilitic aortitis as a reversible mimicker.
  • 1 Feb 2026
  • ARP rheumatology
Emapalumab's role in a severe and treatment-resistant paediatric macrophage activation syndrome.
  • 1 Feb 2026
  • ARP rheumatology
Relapsing polychondritis in a patient treated with Dupilumab.
  • 1 Feb 2026
  • ARP rheumatology

FAQs on Acta Reumatologica Portuguesa